<?xml version="1.0" encoding="UTF-8"?>
<ref id="B50-vaccines-07-00179">
 <label>50.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Oliveira</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>de Oliveira-Filho</surname>
    <given-names>E.F.</given-names>
   </name>
   <name>
    <surname>Fernandes</surname>
    <given-names>A.I.</given-names>
   </name>
   <name>
    <surname>Brito</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Marques</surname>
    <given-names>E.T.</given-names>
   </name>
   <name>
    <surname>Tenorio</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Gil</surname>
    <given-names>L.H.</given-names>
   </name>
  </person-group>
  <article-title>Previous dengue or Zika virus exposure can drive to infection enhancement or neutralisation of other flaviviruses</article-title>
  <source>Mem√≥rias do Instituto Oswaldo Cruz</source>
  <year>2019</year>
  <volume>114</volume>
  <fpage>e190098</fpage>
  <pub-id pub-id-type="doi">10.1590/0074-02760190098</pub-id>
  <pub-id pub-id-type="pmid">31411310</pub-id>
 </element-citation>
</ref>
